Ruoxi Chen is based in New York, joined Warburg Pincus in 2011, and focuses on investments in the healthcare sector. Prior to joining Warburg Pincus, Mr. Chen worked at the Carlyle Group in the U.S. Buyout Fund, and at Citigroup. Mr. Chen is a member of the Board of Directors of Accriva Diagnostics, ComplexCare Solutions, Singular Bio, Silk Road Medical, and Vertice Pharma. He received a B.S. magna cum laude in economics and computer science from Duke University and an M.B.A. from Harvard Business School.
3:30 PM - 4:25 PM (PDT)
Tuesday, June 9
Join Wainwright Fishburn, Partner and Global Chair, Digital Health at Cooley, for a digital health…